EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART

Merle Henderson iD, Peter Dutey-Magni, Carolina Herrera, Wolfgang Stöhr, Alejandro Arenas-Pinto, Owen Swann, Amanda Heslegrave, Henrik Zetterberg, John Tregoning, Sarah Fidler iD, François Raffi, Andrea Calcagno iD und 2 weitere

HIV Medicine · 2026-07 · 27 (7) · 1132-1143

DOI: 10.1111/hiv.70236 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift HIV Medicine, online erschienen am 16.04.2026. Verfasst von Merle Henderson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Biomarkers, HIV Infections, Anti-HIV Agents, Anti-Retroviral Agents. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEAT-ID, European Union, Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data on changes in biomarkers of brain health, and their associations with cognitive function in adults commencing either dual‐ or triple‐antiretroviral therapy (ART) are sparse.

Methods

Plasma biomarkers (neurofilament light [NfL], glial fibrillary acidic protein [GFAP], sCD14, CXCL10, neopterin and IL‐6) were measured at baseline and after 96 weeks on ART in individuals randomized to darunavir/ritonavir and either tenofovir‐DF/emtricitabine (triple‐ART, n = 119) or raltegravir (dual‐ART, n = 119) in NEAT‐001/ANRS143. Regression models examined associations of baseline and week‐96 biomarker concentrations with HIV clinical parameters, composite cognitive test scores (Standardized neuropsychological test [NPZ], 7‐domains) and treatment arm.

Results

In 238 individuals, median age was 38 (interquartile range [IQR] 31, 46) years, 87% male and 83% of white ethnicity. Baseline median log 10 HIV RNA 4.73 (IQR 4.23, 5.11) copies/mL and CD4 350 (IQR 285, 412) cells/mm 3 . At baseline, higher biomarker concentrations were associated with lower CD4 (NfL, GFAP, CXCL10; p < 0.03), higher log 10 HIV RNA (sCD14, neopterin, CXCL10; p < 0.02) and longer known duration of HIV (sCD14; p = 0.044). At week‐96, 94% had plasma HIV 0.05). A greater decline in neopterin concentration was observed with dual‐ (−50.2%) versus triple‐ART (−44.3%; p = 0.022).

Conclusions

Plasma biomarkers of brain health improved following ART initiation, associated predominantly with improvements in CD4 count and partly with treatment arm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersHIV InfectionsAnti-HIV AgentsAnti-Retroviral AgentsHumansMaleFemaleAdultNeopterinChemokine CXCL10Middle AgedLongitudinal StudiesNeurofilament ProteinsGlial Fibrillary Acidic ProteinInterleukin-6Antiretroviral Therapy, Highly ActiveLipopolysaccharide ReceptorsCD4 Lymphocyte CountNeuropsychological TestsInflammation

Stichwörter der Autor:innen

antiretroviral therapybiomarkerscentral nervous systemcognitive functionneuroinflammation

Substanzen

BiomarkersNeopterinChemokine CXCL10CXCL10 protein, humanNeurofilament ProteinsGlial Fibrillary Acidic Proteinneurofilament protein LInterleukin-6GFAP protein, humanAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.
  • NIHR Imperial College London Biomedical Research Centre, London, UK.
  • Jefferiss Wing, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • MRC Clinical Trials Unit, University College London, London, UK.
  • CONRAD, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia, USA.
  • UK Dementia Research Institute, University College London, London, UK.

ORCID-Profile: Merle Henderson, Sarah Fidler, Andrea Calcagno

Förderung

  • NEAT-ID
  • European Union
  • Gilead Sciences
  • Janssen Pharmaceuticals
  • Merck Laboratories
  • The French National Institute of Health and Medical Research
  • National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre
  • UK Dementia Research Institute

Zitieren

APA

Henderson, M., Dutey-Magni, P., Herrera, C., Stöhr, W., Arenas-Pinto, A., Swann, O., Heslegrave, A., Zetterberg, H., Tregoning, J., Fidler, S., Raffi, F., Calcagno, A., Babiker, A., & Winston, A. (2026). Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART. HIV Medicine, 27(7), 1132-1143. https://doi.org/10.1111/hiv.70236

Vancouver

Henderson M, Dutey-Magni P, Herrera C, Stöhr W, Arenas-Pinto A, Swann O, et al. Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART. HIV Medicine. 2026;27(7):1132-1143. doi:10.1111/hiv.70236

BibTeX
@article{Henderson2026,
  author = {Henderson, Merle and Dutey-Magni, Peter and Herrera, Carolina and Stöhr, Wolfgang and Arenas-Pinto, Alejandro and Swann, Owen and Heslegrave, Amanda and Zetterberg, Henrik and Tregoning, John and Fidler, Sarah and Raffi, François and Calcagno, Andrea and Babiker, Ab and Winston, Alan},
  title = {Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART},
  journal = {HIV Medicine},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {1132--1143},
  doi = {10.1111/hiv.70236}
}
Kostenlos starten →